Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2025 Aug 4;223(3):161-167.
doi: 10.5694/mja2.52696. Epub 2025 Jun 22.

Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes

Affiliations
Practice Guideline

Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes

Arianne Sweeting et al. Med J Aust. .

Abstract

Introduction: In the context of a global obesity and diabetes epidemic, gestational diabetes mellitus and other forms of hyperglycaemia in pregnancy are increasingly common. Hyperglycaemia in pregnancy is associated with short and long term complications for both the woman and her baby. These 2025 consensus recommendations from the Australasian Diabetes in Pregnancy Society (ADIPS) update the guidance for the screening, diagnosis and classification of hyperglycaemia in pregnancy based on available evidence and stakeholder consultation.

Main recommendations: Overt diabetes in pregnancy (overt DIP) should be diagnosed at any time in pregnancy if one or more of the following criteria are met: (i) fasting plasma glucose (FPG) ≥ 7.0 mmol/L; (ii) two-hour plasma glucose (2hPG) ≥ 11.1 mmol/L following a 75 g two-hour pregnancy oral glucose tolerance test (POGTT); and/or (iii) glycated haemoglobin (HbA1c) ≥ 6.5% (≥ 48 mmol/mol). Irrespective of gestation, gestational diabetes mellitus should be diagnosed using one or more of the following criteria during a 75 g two-hour POGTT: (i) FPG ≥ 5.3-6.9 mmol/L; (ii) one-hour plasma glucose (1hPG) ≥ 10.6 mmol/L; (iii) 2hPG ≥ 9.0-11.0 mmol/L. Women with risk factors for hyperglycaemia in pregnancy should be advised to have the HbA1c measured in the first trimester. Women with HbA1c ≥ 6.5% (≥ 48 mmol/mol) should be diagnosed and managed as having overt DIP. Before 20 weeks' gestation, and ideally between ten and 14 weeks' gestation, if tolerated, women with a previous history of gestational diabetes mellitus or early pregnancy HbA1c ≥ 6.0-6.4% (≥ 42-47 mmol/mol), but without diagnosed diabetes, should be advised to undergo a 75 g two-hour POGTT. All women (without diabetes already detected in the current pregnancy) should be advised to undergo a 75 g two-hour POGTT at 24-28 weeks' gestation.

Changes in management as a result from this consensus statement: These updated recommendations raise the diagnostic glucose thresholds for gestational diabetes mellitus and clarify approaches to early pregnancy screening for women with risk factors for hyperglycaemia in pregnancy.

Keywords: Diabetes; Diabetes complications; Diabetes mellitus, type 1; Diabetes mellitus, type 2; Diagnostic tests and procedures; Mass screening; Pregnancy; Pregnancy complications; Pregnancy in diabetics; gestational; high‐risk.

PubMed Disclaimer

Conflict of interest statement

Matthew Hare has received honoraria for lectures and consultancies from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Novo Nordisk. Rosemary Hall has received speaking honoraria from Novo Nordisk, Sanofi, Eli Lilly and Dexcom, and served on the New Zealand Diabetes Advisory Boards for Boehringer Ingelheim, Dexcom, Abbott and Novo Nordisk. David Simmons has received honoraria for lectures and consultancies from Novo Nordisk, Ascensia, Abbott and Sanofi, educational grants from Boehringer Ingelheim and Asensia, and equipment from Roche. The Australasian Diabetes in Pregnancy Society has received industry sponsorship for conferences and research grants.

Similar articles

References

    1. Report of a World Health Organization Consultation: diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract 2014; 103: 341‐363. - PubMed
    1. Sweeting A, Wesley H, Backman H, et al. Epidemiology and management of gestational diabetes. Lancet 2024; 404: 175‐192. - PubMed
    1. HAPO Study Cooperative Research Group ; Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. New Eng J Med 2008; 358: 1991‐2002. - PubMed
    1. Bardugo et al. Glucose intolerance in pregnancy and risk of early‐onset type 2 diabetes: a population‐based cohort study. Lancet Diabetes Endocrinol 2023; 11: 333‐344. - PubMed
    1. Daly BM, Wu Z, Nirantharakumar K, et al. Increased risk of cardiovascular and renal disease, and diabetes for all women diagnosed with gestational diabetes mellitus in New Zealand — a national retrospective cohort study. J Diabetes 2024; 16: e13535. - PMC - PubMed

Publication types